Cargando…

Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: Synthesis and characterization

The salt of Aurintricarboxylic acid (ATA) was utilized in this study to synthesize new alkaline earth metal ion complexes. The analytical results proposed the isolation of mononuclear (Sr(+2)&Ba(+2)) and binuclear complexes (Mg(+2)&Ca(+2)). These complexes were analyzed by available analytic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Refat, Moamen S., Sedayo, Anas A., Sayqal, Ali, Alharbi, Arwa, Katouah, Hanadi A., Abumelha, Hana M., Alzahrani, Seraj, Alkhatib, Fatmah, Althagafi, Ismail, El-Metwaly, Nashwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843113/ https://www.ncbi.nlm.nih.gov/pubmed/33531865 http://dx.doi.org/10.1016/j.inoche.2021.108472

Ejemplares similares

Optical Detection of Acetone Using “Turn-Off” Fluorescent Rice Straw Based Cellulose Carbon Dots Imprinted onto Paper Dipstick for Diabetes Monitoring
por: Alshareef, Mubark, et al.
Publicado: (2022)

Inhibition of Orbivirus Replication by Aurintricarboxylic Acid
por: Alonso, Celia, et al.
Publicado: (2020)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

Novel Iron Oxide Nanoparticle-Fortified Carbon Paste Electrode for the Sensitive Voltammetric Determination of Atomoxetine
por: Abumelha, Hana M., et al.
Publicado: (2023)

Hydroxychloroquine/lopinavir/ritonavir: Exanthema and eosinophilia: 12 case reports
Publicado: (2020)

Dexamethasone/hydroxychloroquine/lopinavir/ritonavir: Various toxicities: case report
Publicado: (2021)

Spectral, Molecular Modeling, and Biological Activity Studies on New Schiff's Base of Acenaphthaquinone Transition Metal Complexes
por: Abou Melha, Khlood S., et al.
Publicado: (2021)

Aurintricarboxylic acid increases yield of HSV-1 vectors
por: Pechan, Peter, et al.
Publicado: (2014)

Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid
por: Park, Jun-Gyu, et al.
Publicado: (2019)

Hydroxychloroquine/lopinavir/ritonavir: Various side effects: 7 case reports
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Bradycardia and off-label-use: case report
Publicado: (2021)

Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
por: He, Runtao, et al.
Publicado: (2004)

New Series of Thiazole Derivatives: Synthesis, Structural Elucidation, Antimicrobial Activity, Molecular Modeling and MOE Docking
por: Althagafi, Ismail, et al.
Publicado: (2019)

Simple Preparation of Multifunctional Luminescent Textile for Smart Packaging
por: Al-Qahtani, Salhah D., et al.
Publicado: (2022)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex
por: Che, Kepeng, et al.
Publicado: (2022)

Nano-MOFs as targeted drug delivery agents to combat antibiotic-resistant bacterial infections
por: Ahmed, Saleh A., et al.
Publicado: (2020)

Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
por: Echarte-Morales, Julio, et al.
Publicado: (2021)

Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
por: Schneider, Johanna, et al.
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Guillain-Barre-syndrome and off-label-use: case report
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Lack of efficacy and off label use: 3 case reports
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2009)

Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
por: Marzolini, Catia, et al.
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir/tocilizumab: Lack of efficacy following off label use: case report
Publicado: (2022)

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
por: Ader, Florence, et al.
Publicado: (2021)

Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2013)

Aurintricarboxylic Acid Decreases RNA Toxicity in a C. elegans Model of Repeat Expansions
por: Braun, Maya, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Acute generalised exanthematous pustulosis with erythema multiforme-like lesions: case report
Publicado: (2020)

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2021)

A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
por: Maciorowski, Dawid, et al.
Publicado: (2020)

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results
por: Ader, Florence
Publicado: (2022)

Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on SARS-CoV polymerase and other proteins
por: Yap, YeeLeng, et al.
Publicado: (2005)

Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro
por: Arya, Rimanshee, et al.
Publicado: (2023)

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
por: Uzunova, Katya, et al.
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir/methylprednisolone: Manic episode with psychotic features during an off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Brugada-like ECG pattern following off-label use: case report
Publicado: (2021)

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Drug ineffectiveness following off-label use in COVID-19 infection: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_62c5vjvce58re2l3g3hapjnae8